Table 5.
PTV statistics for all patients under Quad cost
| Case | Homogeneity | D95 | D98 | D99 | Dmax | D95 | D98 | D99 | Dmax | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MAN | L2,1/2 | L2,1 | L2,1/2 – MAN (GyRBE) | L2,1 – MAN (GyRBE) | ||||||||
| H&N#1 | 0.972 | 0.979 | 0.969 | −0.003 | −0.245 | −0.542 | −0.298 | +0.017 | −0.074 | −0.180 | +0.214 | |
| H&N#2 | 0.972 | 0.974 | 0.970 | +0.018 | +0.159 | +0.313 | −0.246 | +0.017 | +0.077 | +0.149 | +0.053 | |
| H&N#3 | 0.981 | 0.981 | 0.972 | −0.006 | −0.061 | −0.173 | +0.069 | +0.013 | −0.207 | −0.368 | +0.723 | |
| CHDM | PTV6300 | 0.918 | 0.916 | 0.917 | −0.003 | −0.030 | −0.060 | +0.126 | −0.012 | −0.012 | −0.050 | −0.055 |
| PTV7400 | 0.953 | 0.953 | 0.953 | −0.012 | −0.012 | −0.050 | −0.055 | −0.028 | −0.058 | −0.042 | −0.054 | |